OGA Gene

Name O-GlcNAcase
Description The dynamic modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) addition and removal on serine and threonine residues is catalyzed by OGT (MIM 300255), which adds O-GlcNAc, and MGEA5, a glycosidase that removes O-GlcNAc modifications (Gao et al., 2001 [PubMed 11148210]).[supplied by OMIM, Mar 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nO‐GlcNAcase (OGA) is the sole enzyme responsible for the removal of O‐linked N‑acetylglucosamine from serine and threonine residues of intracellular proteins, thereby dynamically regulating diverse signaling pathways much like phosphorylation. Initial cloning and characterization of human brain OGA established its biochemical properties, including its pH optimum, substrate selectivity for GlcNAc over similar sugars, and predominant cytoplasmic localization (1). Detailed kinetic and mechanistic studies have further demonstrated that OGA’s catalytic efficiency is driven largely by recognition of the GlcNAc moiety, independent of the peptide context, as evidenced by invariant kcat/Km values across a spectrum of substrates (3, 4). High‐resolution structural analyses, including crystal structures of truncated OGA, revealed an unusual arm‐in‐arm dimer formation with a conserved substrate‐binding cleft that accommodates glycopeptide substrates in a bidirectional yet conserved manner (13, 14, 15). Moreover, studies using chemically modified, S‐linked GlcNAc analogues have confirmed that such surrogates are enzymatically stable proxies for O‑GlcNAc, thereby underscoring the precision of OGA’s glycoside hydrolase activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAltered expression or activity of OGA has been implicated in several human pathologies. In various cancers, decreased levels of MGEA5 transcripts—the gene encoding OGA—correlate with higher tumor grade and poor differentiation, and chromosomal rearrangements involving MGEA5 have been observed in certain soft tissue neoplasms (2, 5, 6, 10). In colorectal and bladder carcinomas, dysregulation of OGA (including its knockdown) is associated with increased global O‑GlcNAcylation, which in turn influences cell morphology, adhesion, and metastatic potential (8, 9). Furthermore, OGA’s modulation of cellular metabolism is highlighted by its ability to regulate aerobic glycolysis via inhibition of pyruvate kinase M2, thereby promoting tumor growth (11). In the cardiovascular context, microRNA‑mediated suppression of OGA (for example, by miR‑539) contributes to increased O‑GlcNAcylation in failing hearts, linking OGA activity to adaptive responses in heart failure (12)."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in cancer and metabolism, OGA is critical in diverse cellular processes and disease contexts. In hematopoietic and leukemic systems, modulation of O‑GlcNAc cycling—including OGA activity—affects the balance between stem cell self‑renewal and differentiation, contributing to acute myeloid leukemia pathogenesis (16, 18, 19). In endothelial cells, conditions such as nucleoside diphosphate kinase‑B deficiency suppress OGA activity, leading to enhanced O‑GlcNAcylation and consequent vascular dysfunction in diabetes (16). Furthermore, OGA is implicated in gene regulatory mechanisms; for example, its recruitment to promoter regions facilitates assembly of repressor complexes that fine‑tune gamma‑globin gene expression (18). In the context of DNA damage repair, OGA is targeted to lesion sites to mediate deglycosylation, thereby contributing to efficient repair processes (20). Notably, pharmacological inhibition of OGA—using agents that increase O‑GlcNAc levels—has been shown to reduce the cellular uptake of pathogenic α‑synuclein fibrils, suggesting potential neuroprotective benefits in Parkinson’s disease, while viral oncoproteins such as HTLV‑1 Tax directly interact with and inhibit OGA to modulate viral transcription (21, 22)."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Y Gao, L Wells, F I Comer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M010420200"}], "href": "https://doi.org/10.1074/jbc.M010420200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11148210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11148210"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ian R Greig, Matthew S Macauley, Ian H Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Probing synergy between two catalytic strategies in the glycoside hydrolase O-GlcNAcase using multiple linear free energy relationships."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Chem Soc (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/ja904506u"}], "href": "https://doi.org/10.1021/ja904506u"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19715310"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19715310"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Marianne Schimpl, Alexander W Schüttelkopf, Vladimir S Borodkin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human OGA binds substrates in a conserved peptide recognition groove."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20101338"}], "href": "https://doi.org/10.1042/BJ20101338"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20863279"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20863279"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Baobin Li, Hao Li, Lei Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.3390"}], "href": "https://doi.org/10.1038/nsmb.3390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28319083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28319083"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Cesar A De Leon, Paul M Levine, Timothy W Craven, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acs.biochem.7b00268"}], "href": "https://doi.org/10.1021/acs.biochem.7b00268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28627871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28627871"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Omid Tavassoly, Jefferey Yue, David J Vocadlo "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.15349"}], "href": "https://doi.org/10.1111/febs.15349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32365408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32365408"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "E A Cameron, V L Martinez-Marignac, A Chan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MGEA5-14 polymorphism and type 2 diabetes in Mexico City."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajhb.20639"}], "href": "https://doi.org/10.1002/ajhb.20639"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17546623"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17546623"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anna Krześlak, Ewa Forma, Magdalena Bernaciak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene expression of O-GlcNAc cycling enzymes in human breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10238-011-0138-5"}], "href": "https://doi.org/10.1007/s10238-011-0138-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21567137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21567137"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Cristina R Antonescu, Lei Zhang, G Petur Nielsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20897"}], "href": "https://doi.org/10.1002/gcc.20897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21717526"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21717526"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Galit Yehezkel, Liz Cohen, Adi Kliger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.345546"}], "href": "https://doi.org/10.1074/jbc.M112.345546"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22730328"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22730328"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Waldemar Rozanski, Anna Krzeslak, Ewa Forma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2012)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22783592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22783592"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jodi M Carter, William R Sukov, Elizabeth Montgomery, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0000000000000212"}], "href": "https://doi.org/10.1097/PAS.0000000000000212"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24705316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24705316"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Senthilkumar Muthusamy, Angelica M DeMartino, Lewis J Watson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.578682"}], "href": "https://doi.org/10.1074/jbc.M114.578682"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25183011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25183011"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ayako Makino, Anzhi Dai, Ying Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00069.2015"}], "href": "https://doi.org/10.1152/ajpcell.00069.2015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26269457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26269457"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Anupriya Chatterjee, Rachana Eshwaran, Gernot Poschet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cells (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cells9102324"}], "href": "https://doi.org/10.3390/cells9102324"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33086728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33086728"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yaqi Cui, Rong Xie, Xuefang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OGA is associated with deglycosylation of NONO and the KU complex during DNA damage repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-03910-6"}], "href": "https://doi.org/10.1038/s41419-021-03910-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34135314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34135314"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sudjit Luanpitpong, Napachai Rodboon, Parinya Samart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/stmcls/sxac068"}], "href": "https://doi.org/10.1093/stmcls/sxac068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36124999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36124999"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ping Lu, Yusong Liu, Maozhou He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-023-42427-8"}], "href": "https://doi.org/10.1038/s41467-023-42427-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37907462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37907462"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yunyan Du, Zhangjian Yang, Hao Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-024-06729-z"}], "href": "https://doi.org/10.1038/s41419-024-06729-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38755129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38755129"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Qianyu Liu, Cheng Chen, Zhiya Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "O-GlcNAcase regulates pluripotency states of human embryonic stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cell Reports (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.stemcr.2024.05.009"}], "href": "https://doi.org/10.1016/j.stemcr.2024.05.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38942028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38942028"}]}]}]}
NCBI Gene ID 10724
API
Download Associations
Predicted Functions View OGA's ARCHS4 Predicted Functions.
Co-expressed Genes View OGA's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View OGA's ARCHS4 Predicted Functions.

Functional Associations

OGA has 11,550 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 41 datasets.

Click the + buttons to view associations for OGA from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of OGA gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of OGA gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Proteomics Cell lines associated with OGA protein from the CCLE Cell Line Proteomics dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of OGA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of OGA gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing OGA protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with OGA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of OGA protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by OGA gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DGIdb Drug Targets 2026 interacting drugs for OGA protein from the DGIdb Drug Targets 2026 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with OGA gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with OGA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with OGA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with OGA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding OGA protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2023 biological processes involving OGA gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving OGA gene from the curated GO Biological Process Annotations2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by OGA gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by OGA gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of OGA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with OGA gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of OGA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of OGA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving OGA protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of OGA gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of OGA gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by OGA gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of OGA gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PFOCR Pathway Figure Associations 2023 pathways involving OGA protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving OGA protein from the Wikipathways PFOCR 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of OGA gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of OGA gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of OGA gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of OGA gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of OGA gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of OGA gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of OGA gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of OGA gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of OGA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of OGA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with OGA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.